Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Diagnostic Performance of Nonhyperemic Pressure Ratios Assessed by 13N-Ammonium Positron Emission Tomography.

Lee JM, Hwang D, Choi KH, Kim CH, Bang JI, Suh M, Paeng JC, Cheon GJ, Koo BK.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1517-1518. doi: 10.1016/j.jcin.2019.04.017. No abstract available.

PMID:
31395224
2.

Assessment of Inflammation in Pulmonary Artery Hypertension by 68Ga-Mannosylated Human Serum Albumin.

Park JB, Suh M, Park JY, Park JK, Kim YI, Kim H, Cho YS, Kang H, Kim K, Choi JH, Nam JW, Kim HK, Lee YS, Jeong JM, Kim YJ, Paeng JC, Lee SP.

Am J Respir Crit Care Med. 2019 Jul 19. doi: 10.1164/rccm.201903-0639OC. [Epub ahead of print]

PMID:
31322420
3.

Evaluation of maximum standardized uptake value at fluorine-18 fluorodeoxyglucose positron emission tomography as a complementary T factor in the eighth edition of lung cancer stage classification.

Kim H, Goo JM, Paeng JC, Kim YT, Park CM.

Lung Cancer. 2019 Aug;134:151-157. doi: 10.1016/j.lungcan.2019.06.013. Epub 2019 Jun 13.

PMID:
31319974
4.

Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.

Kang YK, Choi JY, Paeng JC, Kim YI, Kwon HW, Cheon GJ, Suh KS, Kwon CHD, Lee DS, Kang KW.

Eur Radiol. 2019 May 21. doi: 10.1007/s00330-019-06239-z. [Epub ahead of print]

PMID:
31115626
5.

Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly.

Kim HM, Sohn DW, Paeng JC.

Int Heart J. 2019 May 30;60(3):643-647. doi: 10.1536/ihj.18-345. Epub 2019 Apr 25.

6.

Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.

Kolossváry M, Park J, Bang JI, Zhang J, Lee JM, Paeng JC, Merkely B, Narula J, Kubo T, Akasaka T, Koo BK, Maurovich-Horvat P.

Eur Heart J Cardiovasc Imaging. 2019 Mar 5. pii: jez033. doi: 10.1093/ehjci/jez033. [Epub ahead of print]

PMID:
30838375
7.

Radiomics in Oncological PET/CT: a Methodological Overview.

Ha S, Choi H, Paeng JC, Cheon GJ.

Nucl Med Mol Imaging. 2019 Feb;53(1):14-29. doi: 10.1007/s13139-019-00571-4. Epub 2019 Jan 15. Review.

PMID:
30828395
8.

Generation of PET Attenuation Map for Whole-Body Time-of-Flight 18F-FDG PET/MRI Using a Deep Neural Network Trained with Simultaneously Reconstructed Activity and Attenuation Maps.

Hwang D, Kang SK, Kim KY, Seo S, Paeng JC, Lee DS, Lee JS.

J Nucl Med. 2019 Aug;60(8):1183-1189. doi: 10.2967/jnumed.118.219493. Epub 2019 Jan 25.

PMID:
30683763
9.

FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.

Koh Y, Lee JM, Woo GU, Paeng JC, Youk J, Yoon SS, Kim I, Kang KW.

Clin Nucl Med. 2019 Jan;44(1):4-10. doi: 10.1097/RLU.0000000000002320.

PMID:
30371574
10.

Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma.

Kim HJ, Lee R, Choi H, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW.

Nucl Med Mol Imaging. 2018 Oct;52(5):342-349. doi: 10.1007/s13139-018-0543-8. Epub 2018 Aug 30.

PMID:
30344782
11.

Recurrence of Melanoma After Initial Treatment: Diagnostic Performance of FDG PET in Posttreatment Surveillance.

Lee HH, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW.

Nucl Med Mol Imaging. 2018 Oct;52(5):327-333. doi: 10.1007/s13139-018-0537-6. Epub 2018 Aug 8.

PMID:
30344780
12.

Significance of 18F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.

Kim E, Wu HG, Keam B, Kim TM, Kim DW, Paeng JC, Kim HJ, Chang JH.

Clin Lung Cancer. 2019 Jan;20(1):e9-e23. doi: 10.1016/j.cllc.2018.08.018. Epub 2018 Aug 30.

PMID:
30266585
13.

A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.

Kim M, Kim TM, Keam B, Kim YJ, Paeng JC, Moon KC, Kim DW, Heo DS.

Oncologist. 2019 Jan;24(1):20-e29. doi: 10.1634/theoncologist.2018-0464. Epub 2018 Sep 25.

14.

Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study.

Park EH, Lee EY, Lee YJ, Ha YJ, Yoo WH, Choi BY, Paeng JC, Suh HY, Song YW.

Rheumatol Int. 2018 Dec;38(12):2233-2242. doi: 10.1007/s00296-018-4159-1. Epub 2018 Sep 18.

15.

Adenine Nucleotide Translocase 2 as an Enzyme Related to [18F] FDG Accumulation in Various Cancers.

Lee CH, Kim MJ, Lee HH, Paeng JC, Park YJ, Oh SW, Chai YJ, Kim YA, Cheon GJ, Kang KW, Youn H, Chung JK.

Mol Imaging Biol. 2019 Aug;21(4):722-730. doi: 10.1007/s11307-018-1268-x.

PMID:
30225759
16.

Measurement of 68Ga-DOTATOC Uptake in the Thoracic Aorta and Its Correlation with Cardiovascular Risk.

Lee R, Kim J, Paeng JC, Byun JW, Cheon GJ, Lee DS, Chung JK, Kang KW.

Nucl Med Mol Imaging. 2018 Aug;52(4):279-286. doi: 10.1007/s13139-018-0524-y. Epub 2018 May 22.

17.

Coronary computed tomography angiography vs. myocardial single photon emission computed tomography in patients with intermediate risk chest pain: a randomized clinical trial for cost-effectiveness comparison based on real-world cost.

Lee SP, Seo JK, Hwang IC, Park JB, Park EA, Lee W, Paeng JC, Lee HJ, Yoon YE, Kim HL, Koh E, Choi I, Choi JE, Kim YJ.

Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):417-425. doi: 10.1093/ehjci/jey099.

PMID:
30052964
18.

Prognostic Value of Baseline 18F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study.

Moon SH, Choi WH, Yoo IR, Lee SJ, Paeng JC, Jeong SY, Lee SW, Kim K, Choi JY.

Korean J Radiol. 2018 May-Jun;19(3):481-488. doi: 10.3348/kjr.2018.19.3.481. Epub 2018 Apr 6.

19.

Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.

Kim YI, Paeng JC, Park YS, Cheon GJ, Lee DS, Chung JK, Kang KW.

AJR Am J Roentgenol. 2018 Jun;210(6):1346-1351. doi: 10.2214/AJR.17.18916. Epub 2018 Mar 16.

PMID:
29547059
20.

Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.

Joo I, Kim HC, Kim GM, Paeng JC.

Korean J Radiol. 2018 Mar-Apr;19(2):209-222. doi: 10.3348/kjr.2018.19.2.209. Epub 2018 Feb 22. Review.

Supplemental Content

Loading ...
Support Center